Bibliography
- KOKKI H, RASANEN I, REINIKAINEN M et al.: Pharmacokinetics of oxycodone after intravenous, buccal, intramuscular and gastric administration in children. Clin. Pharmacokinet. (2004) 43(9):613-622.
- ROWLAND M, TOZER TN: Absorption. In: Clinical Pharmacokinetics: Concepts and Applications. (Chapter 9), (3rd Edition). Lippincott Williams & Wilkins, New York, USA (1995):126-128.
- GREEN SM, ROTHROCK SG: Single-dose intramuscular ceftriaxone for acute otitis media in children. Pediatrics (1993) 91:23-30.
- SIMONS FER, ROBERTS JR, GU XIAOCHEN, SIMONS KJ: Epinephrine absorption in children with a history of anaphylaxis. J. Allergy Clin. Immunol. (1998) 101:33-37.
- TUOMILEHTO H, KOKKI H: Parenteral ketoprofen for pain management after adenoidectomy: comparison of intravenous and intramuscular routes of administration. Acta Anaesthesiol. Scand. (2002) 46:184-189.
- RITSCHEL WA, KEARNS GL: Handbook of Basic Pharmacokinetics. Including Clinical Applications. (6th Edition). American Pharmacists Association. Washington, DC, USA (2004):228-229.
- REED MD, YAMASHITA TS, KNUPP CK et al.: Pharmacokinetics of intravenously and intramuscularly administered cefepime in infants and children. Antimicrob. Agents Chemother. (1997) 41(8):1783-1787.
- KAUFFMAN RE: Drug action and therapy in the infant and child. In: Neonatal and Pediatric Pharmacology. Therapeutic Principles in Practice. (Chapter 3), (3rd Edition). Yaffe SJ, Aranda JV (Eds), Lippincott Williams & Wilkins. New York, USA (2004):20-31.
- LOEBSTEIN R, KOREN G: Clinical pharmacology and therapeutic drug monitoring in neonates and children. Pediatr. Rev. (1998) 19(12):423-428.
- Physiologic factors related to drug absorption. Chapter 13. In: Applied Biopharmaceutics & Pharmacokinetics. (5th Edition). Shargel L, Wu-Pong S, Yu ABC (Eds), McGraw-Hill, New York, USA (2005).
- HILDICK-SMITH G, SCOTT TF, WHITLOCK CM: Penicillin regimens in pediatric practice. Study of blood levels. Pediatrics (1950) 5(1):97-113.
- BLUMER JL, REED MD, KAPLAN EL, DRUSANO GL: Ceftriaxone in group A streptococcal tonsillopharyngitis: a reverse engineering solution using pharmacodynamic modeling. Pediatrics (2005) 116:927-932.
- KAFETZIS DA, SINANIOTIS CA, PAPADATOS CJ, KOSMIDIS J: Pharmacokinetics of amikacin in infants and pre-school children. Acta Paediatr. Scand. (1979) 68:419-422.
- GREENBLATT DJ, KOCH-WESER J: Intramuscular injection of drugs. N. Engl. J. Med. (1076) 295:542-546.
- CARRY MR, RINGEL SP, STARCEVICH JM: Distribution of capillaries in normal and diseased human skeletal muscle. Muscle Nerve (1986) 9:445-454.
- LADE RI, DIEHL AM, SNYDER I, HAMILTON TR: Concentration of penicillin in the serum following intramuscular administration of benzathine penicillin G to children with inactive rheumatic fever. Pediatrics (1958) 21(2):233-242.
- HARDING SM, EILON LA, HARRIS AM: Factors affecting the intramuscular absorption of cefuroxime. J. Antimicrob. Chemother. (1979) 5:87-93.
- KEARNS GL, ABDEL-RAHMAN SM, ALANDER SW, BLOWEY DL, LEEDER JS, KAUFFMAN RE: Developmental pharmacology – drug disposition, action, and therapy in infants and children. N. Engl. J. Med. (2003) 349:1157-1167.
- BERGESON PS, SINGER SA, KAPLAN AM: Intramuscular injections in children. Pediatrics (1982) 70(6):944-948.
- SEATON C, IGNAS J, MUCHOHI S et al.: Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition. J. Antimicrob. Chemother. (2007) 59:681-689.
- BLUMER J, REED M, KNUPP C: Review of the pharmacokinetics of cefepime in children: the safety and efficacy of cefepime in pediatrics. Pediatr. Infect. Dis. J. (2001) 20:337-342.
- DASCHNER F, REISS E, ENGERT J: Distribution of amikacin in serum, muscle, and fat in children after a single intramuscular injection. Antimicrob. Agents Chemother. (1977) 11(6):1081-1083.
- KRISHNA S, NAGARAJA NV, PLANCHE T et al.: Population pharmacokinetics of intramuscular quinine in children with severe malaria. Antimicrob. Agents Chemother. (2001) 45(6):1803-1808.
- FERRE PJ, LAROUTE V, BRAUN JP et al.: Simultaneous and minimally invasive assessment, tolerance and bioavailability of different volumes of an intramuscular formulation in the same animals. J. Anim. Sci. (2006) 84:1295-1301.
- NOUWS JF: Irritation, bioavailability, and residue aspects of ten oxytetracycline formulations administered intramuscularly to pigs. Vet. Q. (1984):60-84.
- BARENNES H: Intramuscular injections in sub-saharan African children, apropos of a frequently misunderstood pathology: the complications related to intramuscular quinine injections. Bull. Soc. Pathol. Exot. (1999) 92(1):33-37.
- STREBEL PM, ION-NEDELCU N, BAUGHMAN AL et al.: Intramuscular injections within 30 days of immunization with oral poliovirus vaccine – a risk factor for vaccine related paralytic poliomyelitis. N. Engl. J. Med. (1995) 332:500-506.
- OSHIDA S, DEGAWA K, TAKAHASHI Y, AKAISHI S: Physico-chemical properties and local toxic effects of injectables. Tohoku J. Exp. Med. (1979) 127(4):301-316.
- WILLIAMS PD, MASTERS BG, EVANS LD et al.: An in vitro model for assessing muscle irritation due to parenteral antibiotics. Toxicol. Sci. (1987) 9(1):10-17.
- TAKETOMO CK, HODDING JH, KRAUS DM: Pediatric Dosage Handbook. (12th Edition). LEXI-COMP, Ohio, USA (2005 – 2006):1569-1570.
Website
- http://www.mdconsult.com/das/book/body/77819584-2/0/1255/1744.html Developmental pharmacology. In: Miller's Anesthesia. (6th Edition). Miller RD (Ed.), Churchill Livingstone (2005). (Accessed 18 March 2007).